BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6806261)

  • 21. Immunological characterization of xenogenic anti-metatype antibodies.
    Weidner KM; Voss EW
    J Biol Chem; 1991 Feb; 266(4):2513-9. PubMed ID: 1899241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic measurements of molecular interactions by spectrofluorometry.
    Voss EW
    J Mol Recognit; 1993 Jun; 6(2):51-8. PubMed ID: 8305251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial elucidation of an anti-hapten repertoire in BALB/c mice: comparative characterization of several monoclonal anti-fluorescyl antibodies.
    Kranz DM; Voss EW
    Mol Immunol; 1981 Oct; 18(10):889-98. PubMed ID: 7335083
    [No Abstract]   [Full Text] [Related]  

  • 24. Active site structure and antigen binding properties of idiotypically cross-reactive anti-fluorescein monoclonal antibodies.
    Bedzyk WD; Herron JN; Edmundson AB; Voss EW
    J Biol Chem; 1990 Jan; 265(1):133-8. PubMed ID: 2104617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-chain site-specific mutations of fluorescein-amino acid contact residues in high affinity monoclonal antibody 4-4-20.
    Denzin LK; Whitlow M; Voss EW
    J Biol Chem; 1991 Jul; 266(21):14095-103. PubMed ID: 1856233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of an anti-single-stranded DNA active site to an anti-fluorescein active site through heavy chain complementarity determining region transplantation.
    Gulliver GA; Bedzyk WD; Smith RG; Bode SL; Tetin SY; Voss EW
    J Biol Chem; 1994 Mar; 269(11):7934-40. PubMed ID: 8132513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal IgM antibody exhibiting high-affinity binding and cryoglobulin properties.
    Ballard DW; Kranz DM; Voss EW
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5071-4. PubMed ID: 6348779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation kinetics of bivalent ligand-immunoglobulin E aggregates in solution.
    Posner RG; Erickson JW; Holowka D; Baird B; Goldstein B
    Biochemistry; 1991 Mar; 30(9):2348-56. PubMed ID: 1900432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence polarization and intensity kinetic studies of antifluorescein antibody obtained at different stages of the immune response.
    Levison SA; Hicks AN; Portmann AJ; Dandliker WB
    Biochemistry; 1975 Aug; 14(17):3778-86. PubMed ID: 1236740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of transplantation of antibody heavy chain complementarity determining regions on ligand binding.
    Gulliver GA; Voss EW
    J Biol Chem; 1994 Sep; 269(39):24040-5. PubMed ID: 7523365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-4-20 anti-fluorescyl IgG Fab' recognition of membrane bound hapten: direct evidence for the role of protein and interfacial structure.
    Leckband DE; Kuhl T; Wang HK; Herron J; Müller W; Ringsdorf H
    Biochemistry; 1995 Sep; 34(36):11467-78. PubMed ID: 7547875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrete bathochromic shifts exhibited by fluorescein ligand bound to rabbit polyclonal anti-fluorescein Fab fragments.
    Voss EW; Croney JC; Jameson DM
    J Protein Chem; 2002 May; 21(4):231-41. PubMed ID: 12168694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-metatype antibodies stabilize the fluorescein single-chain antibody 4-4-20 complex against dissociation by hydrostatic pressure.
    Coelho-Sampaio T; Voss EW
    J Biol Chem; 1994 Mar; 269(11):8146-52. PubMed ID: 8132540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative properties of monoclonal antibodies comprising a high-affinity anti-fluorescyl idiotype family.
    Bates RM; Ballard DW; Voss EW
    Mol Immunol; 1985 Aug; 22(8):871-7. PubMed ID: 3930950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selective interaction of immunoglobulin polypeptide chains. Quantitative evaluation of the idiotypic and antigen binding activity of reassociated immunoglobulin molecules].
    Ibragimov AR; Shliapnikov SV; Maĭsurian NA; Arsen'eva EL; Bogacheva GT
    Mol Biol (Mosk); 1987; 21(1):54-61. PubMed ID: 3106788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature and pH dependence of fluorescein binding within the monoclonal antibody 9-40 active site as monitored by hydrostatic pressure.
    Carrero J; Voss EW
    J Biol Chem; 1996 Mar; 271(10):5332-7. PubMed ID: 8621385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping myosin light chains by immunoelectron microscopy. Use of anti-fluorescyl antibodies as structural probes.
    Katoh T; Lowey S
    J Cell Biol; 1989 Oct; 109(4 Pt 1):1549-60. PubMed ID: 2477378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine structure of three different anti-fluorescein combining sites: induced circular dichroism of hapten bound to autologous and heterologous recombinants.
    Gollogly JR; Cathou RE
    J Immunol; 1976 Jul; 117(1):180-6. PubMed ID: 6594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent perturbation of the fluorescence of fluorescein bound to specific antibody. Fluorescence quenching of the bound fluorophore by iodide.
    Watt RM; Voss EW
    J Biol Chem; 1979 Mar; 254(5):1684-90. PubMed ID: 570194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of secondary forces on the ligand binding and conformational state of antifluorescein monoclonal antibody 9-40.
    Mummert ME; Voss EW
    Biochemistry; 1997 Sep; 36(39):11918-22. PubMed ID: 9305985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.